ConductScience.org, home

Paper12830009

The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.

Moore KP and 12 others. Hepatology, 2003. Cited by 676 papers, by iCite.

Cite this record

ConductScience Library. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Papers, record 12830009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12830009

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
PubMed
Journal
Hepatology
PubMed
Year
2003
PubMed
Publication types
Consensus Statement, Journal Article, Review
PubMed
Citations, by iCite
676
iCite
Relative citation ratio, by iCite
19.3
iCite
Revised in PubMed
2026-01-28
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moore KPKevin P
2Wong FFlorence
3Gines PPere
4Bernardi MMauro
5Ochs AAndreas
6Salerno FFrancesco
7Angeli PPaolo
8Porayko MMichael
9Moreau RRichard
10Garcia-Tsao GGuadelupe
11Jimenez WWladimiro
12Planas RRamon
13Arroyo VVicente

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AscitesMajor topic
Liver CirrhosisMajor topic
Evidence-Based Medicine
Humans

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00986817Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and AlbuminBackgroundClinicalTrials.gov
NCT04043858Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in ChildrenBackgroundClinicalTrials.gov

Download CSV of trials

Cited by292

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 676 citations.

PMIDTitleJournalYearIn PapersSource
42902152Combined TIPS and TACE for patients with hepatocellular carcinoma and variceal bleeding secondary to portal vein tumor thrombus.BMC Gastroenterol2026https://conductscience.org/library/papers/42902152PubMed
42581040
Temperature-sensitive liquid embolic agent transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for BCLC Stage B/C hepatocellular carcinoma: a multicenter real-world study and spatial transcriptomics profiling (CHANCE 2515).
Signal Transduct Target Ther2026https://conductscience.org/library/papers/42581040PubMed
42512363
Exploratory Evaluation of Hepatic Venous Pressure Gradient, Indocyanine Green Retention, and Liver Stiffness in Predicting Short-Term Outcomes After Liver Resection in Patients with Cirrhosis: A Multicenter Prospective Study.
Cancers (Basel)2026https://conductscience.org/library/papers/42512363PubMed
42435328Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites.United European Gastroenterol J2026https://conductscience.org/library/papers/42435328PubMed
42218281Predictors and outcomes of hepatic decompensation following transarterial locoregional therapy in hepatocellular carcinoma.Sci Rep2026https://conductscience.org/library/papers/42218281PubMed
42210133Extracellular volume fraction derived from spectral CT for liver function reserve evaluation and complication prediction in clinically stable liver cirrhosis.BMC Med Imaging2026https://conductscience.org/library/papers/42210133PubMed
42058809Open-label randomized controlled study of salt-restricted vs salt-unrestricted diet in patients with cirrhosis with hyponatremia.World J Methodol2026https://conductscience.org/library/papers/42058809PubMed
42050795KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications 2026.Clin Mol Hepatol2026https://conductscience.org/library/papers/42050795PubMed
42022527Refractory Ascites and the Alfapump.Gastro Hep Adv2026https://conductscience.org/library/papers/42022527PubMed
41976936Prognostic Relevance of Ascites Volume and Dynamics in Outpatients with Cirrhosis: A Prospective Cohort Study.J Clin Med2026https://conductscience.org/library/papers/41976936PubMed
41648734Real-world outcomes of trifluridine/tipiracil for heavily pretreated patients with advanced gastric cancer.ESMO Gastrointest Oncol2024https://conductscience.org/library/papers/41648734PubMed
41572027Persistent Lymphatic Ascites After Liver Transplantation: Identification of the Underlying Mechanism of Ascites Permits Successful Percutaneous Treatment.Cardiovasc Intervent Radiol2026https://conductscience.org/library/papers/41572027PubMed
41417961TIPS improves survival in patients with cirrhosis and recurrent ascites: a multicenter observational study.Int J Surg2025https://conductscience.org/library/papers/41417961PubMed
41384215Diagnostic and Therapeutic Challenges of Hepatoadrenal Syndrome in Advanced Cirrhosis: A Case Report and Literature Review.Cureus2025https://conductscience.org/library/papers/41384215PubMed
41379842Feasibility study of a novel technique for treating refractory ascites using a peritoneobladder shunt in a swine model.PLoS One2025https://conductscience.org/library/papers/41379842PubMed
41268036Long-Term Abdominal Drains in Refractory Ascites Due to Cirrhosis: A Retrospective Cohort Analysis.Cureus2025https://conductscience.org/library/papers/41268036PubMed
41213540[Position paper for the standardized use of transjugular intrahepatic portosystemic shunt (TIPS) in adults].Z Gastroenterol2025https://conductscience.org/library/papers/41213540PubMed
41194902Outcomes in Cirrhosis-Related Refractory Ascites with Emphasis on Palliative Care: Single-Centre Experience and Literature Review.Curr Hepatol Rep2024https://conductscience.org/library/papers/41194902PubMed
41094298Splenic artery embolization for refractory ascites after liver transplantation: a single-center experience.CVIR Endovasc2025https://conductscience.org/library/papers/41094298PubMed
40949845Determining the optimal portal pressure gradient after small-diameter TIPS for ascites: a retrospective study.Ther Adv Gastroenterol2025https://conductscience.org/library/papers/40949845PubMed

See all 292 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12830009

GET https://conductscience.org/api/papers/v1/12830009/cited_by?page=2